Innoviva (INVA)
(Delayed Data from NSDQ)
$15.24 USD
-0.05 (-0.33%)
Updated Mar 28, 2024 03:59 PM ET
After-Market: $15.23 -0.01 (-0.07%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for Innoviva, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 194 | 291 | 202 | 246 | 351 |
Receivables | 84 | 64 | 111 | 94 | 79 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 41 | 56 | 0 | 0 | 0 |
Other Current Assets | 26 | 32 | 1 | 2 | 1 |
Total Current Assets | 344 | 444 | 314 | 342 | 431 |
Net Property & Equipment | 84 | 98 | 111 | 125 | 139 |
Investments & Advances | 561 | 403 | 484 | 438 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 17 | 94 | 154 |
Intangibles | 248 | 280 | 0 | 0 | 0 |
Deposits & Other Assets | 3 | 4 | 0 | 0 | 0 |
Total Assets | 1,244 | 1,232 | 926 | 1,000 | 725 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 7 | 3 | 0 | 0 | 0 |
Current Portion Long-Term Debt | 0 | 96 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 30 | 34 | 6 | 6 | 5 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 1 | 2 | 0 | 0 | 0 |
Total Current Liabilities | 38 | 135 | 6 | 6 | 5 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 1 | 6 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 446 | 444 | 395 | 386 | 377 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 84 | 81 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 569 | 666 | 400 | 392 | 383 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 1 | 1 | 1 | 1 | 1 |
Capital Surplus | 1,093 | 1,164 | 1,264 | 1,261 | 1,259 |
Retained Earnings | -25 | -205 | -456 | -722 | -946 |
Other Equity | 0 | 0 | 111 | 68 | 29 |
Treasury Stock | 394 | 394 | 394 | 0 | 0 |
Total Shareholder's Equity | 675 | 566 | 526 | 608 | 342 |
Total Liabilities & Shareholder's Equity | 1,244 | 1,232 | 926 | 1,000 | 725 |
Total Common Equity | 675 | 566 | 526 | 608 | 342 |
Shares Outstanding | 63.30 | 69.70 | 69.50 | 101.30 | 101.20 |
Book Value Per Share | 10.66 | 8.12 | 7.57 | 6.00 | 3.38 |
Fiscal Year End for Innoviva, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 194 | 180 | 173 | 144 | 291 |
Receivables | 84 | 68 | 81 | 76 | 64 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 41 | 41 | 47 | 50 | 56 |
Other Current Assets | 26 | 17 | 23 | 27 | 32 |
Total Current Assets | 344 | 305 | 324 | 296 | 444 |
Net Property & Equipment | 84 | 88 | 91 | 94 | 98 |
Investments & Advances | 561 | 530 | 433 | 456 | 403 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 5 | 6 | 0 | 0 |
Intangibles | 248 | 255 | 258 | 276 | 280 |
Deposits & Other Assets | 3 | 3 | 4 | 4 | 4 |
Total Assets | 1,244 | 1,188 | 1,118 | 1,130 | 1,232 |
Liabilities & Shareholders Equity | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 7 | 4 | 5 | 6 | 3 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 96 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 30 | 31 | 31 | 30 | 34 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 1 | 2 | 3 | 2 | 2 |
Total Current Liabilities | 38 | 36 | 39 | 38 | 135 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 1 | 0 | 0 | 5 | 6 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 446 | 446 | 445 | 445 | 444 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 84 | 79 | 80 | 81 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 569 | 561 | 563 | 568 | 666 |
Shareholders Equity | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 1 | 1 | 1 | 1 | 1 |
Capital Surplus | 1,093 | 1,107 | 1,117 | 1,125 | 1,164 |
Retained Earnings | -25 | -87 | -169 | -170 | -205 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 394 | 394 | 394 | 394 | 394 |
Total Shareholder's Equity | 675 | 627 | 555 | 561 | 566 |
Total Liabilities & Shareholder's Equity | 1,244 | 1,188 | 1,118 | 1,130 | 1,232 |
Total Common Equity | 675 | 627 | 555 | 561 | 566 |
Shares Outstanding | 63.30 | 64.00 | 65.10 | 69.70 | 69.70 |
Book Value Per Share | 10.66 | 9.80 | 8.53 | 8.06 | 8.12 |